EUVIMEDEUVIMED entdecken
Crossref

The Epidemiology of Central Nervous System Tumors in Arab Countries

Sarah Al Sharie, Mohammad Araydah, Mouness Obeidat, Asem Mansour, Maysa Al-Hussaini

Neuroepidemiology · 2025

DOI: 10.1159/000546703 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuroepidemiology, 2025. Verfasst von Sarah Al Sharie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Office of Scientific Affairs and Research, King Hussein Cancer Center, Amman, Jordan. Hauptthemen laut MEDLINE: Central Nervous System Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Central nervous system (CNS) tumors represent a significant global health burden, with notable regional disparities in incidence, mortality, and survival. The Arab world, comprising 22 countries across the Middle East and North Africa, faces unique epidemiological challenges influenced by population demographics, healthcare access, and genetic factors. This study aims to analyze the incidence, mortality, and 5-year prevalence of CNS tumors in Arab countries using Global Cancer Observatory (GLOBOCAN) 2020 and 2022 data, with comparisons by country, gender, and age-group.

Methods

Data were extracted from the GLOBOCAN “Cancer Today” portal for the years 2020 and 2022. We included all Arab countries and examined trends in crude rates, age-standardized incidence rates (ASIRs), age-standardized mortality rates (ASMRs), and incidence-to-mortality ratios (IMRs), stratified by sex and age-group.

Results

Globally, CNS tumor cases rose from 308,102 in 2020 to 321,731 in 2022 (4.4%), while Arab countries saw an increase from 14,177 to 14,823 cases, (4.6%). Egypt reported the highest incidence, mortality, and prevalence in both years. Iraq demonstrated the highest ASIR and ASMR, while Jordan (in 2020) and Syria (in 2022) had unexpectedly high ASIR and ASMR among males. Older adults (≥50 years) bore the highest disease burden across all regions. Despite modest improvements in survival, the IMR remained relatively low, indicating continued challenges in achieving favorable outcomes, particularly among children and older adults.

Conclusion

The burden of CNS tumors is increasing in the Arab region, with significant inter-country variation. These findings highlight the need for improved cancer registries, early detection programs, and region-specific strategies to enhance diagnosis and treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Nervous System NeoplasmsHumansFemaleIncidenceMaleMiddle EastPrevalenceAdultMiddle AgedChildAdolescentYoung AdultAgedChild, Preschool

Stichwörter der Autor:innen

Arab countriesCNS tumorsEpidemiologyGLOBOCANHealth disparitiesIncidenceMortalityPrevalence

Autor:innen und Institutionen

  • Office of Scientific Affairs and Research, King Hussein Cancer Center, Amman, Jordan.
  • Department of Internal Medicine, Istishari Hospital, Amman, Jordan.
  • Department of Surgery, Neurosurgery Unit, King Hussein Cancer Center, Amman, Jordan.
  • Department of Radiology, King Hussein Cancer Center, Amman, Jordan.
  • Department of Cell Therapy and Applied Genomics, King Hussein Cancer Center, Amman, Jordan, mhussaini@khcc.jo.

Zitieren

APA

Al Sharie, S., Araydah, M., Obeidat, M., Mansour, A., & Al-Hussaini, M. (2025). The Epidemiology of Central Nervous System Tumors in Arab Countries. Neuroepidemiology. https://doi.org/10.1159/000546703

Vancouver

Al Sharie S, Araydah M, Obeidat M, Mansour A, Al-Hussaini M. The Epidemiology of Central Nervous System Tumors in Arab Countries. Neuroepidemiology. 2025. doi:10.1159/000546703

BibTeX
@article{AlSharie2025,
  author = {Al Sharie, Sarah and Araydah, Mohammad and Obeidat, Mouness and Mansour, Asem and Al-Hussaini, Maysa},
  title = {The Epidemiology of Central Nervous System Tumors in Arab Countries},
  journal = {Neuroepidemiology},
  year = {2025},
  doi = {10.1159/000546703}
}
Kostenlos starten →